Affiliation: University of Oslo
- Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapyArne Berg
Faculty of Medicine, University of Oslo, Norway
Int J Cancer 120:1603-9. 2007..In conclusion our study shows that presence of DTCs in BM at diagnosis was associated with the histological differentiation of the primary tumor and an increased risk of developing distant metastases after RT...
- 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapyArne Berg
Faculty of Medicine, University of Oslo, Oslo, Norway
Int J Radiat Oncol Biol Phys 69:1074-83. 2007....
- Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancerArne Berg
Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
Prostate 68:1607-14. 2008....
- Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changesA Berg
Faculty Division The Norwegian Radium Hospital, Faculty of Medicine, University of Oslo, Oslo, Norway
Prostate Cancer Prostatic Dis 12:269-76. 2009..05) lower on physical function and vitality. Estimated free testosterone and measured serum estradiol had increased from baseline in most patients, but did not correlate with HRQoL outcomes 5 years after the start of treatment...